AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)
Clinical trial NCT07640737 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07640737
- Sponsor
- Aurigene Discovery Technologies Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2028-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.